Oculomucocutaneous syndrome

Jump to navigation Jump to search

WikiDoc Resources for Oculomucocutaneous syndrome

Articles

Most recent articles on Oculomucocutaneous syndrome

Most cited articles on Oculomucocutaneous syndrome

Review articles on Oculomucocutaneous syndrome

Articles on Oculomucocutaneous syndrome in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Oculomucocutaneous syndrome

Images of Oculomucocutaneous syndrome

Photos of Oculomucocutaneous syndrome

Podcasts & MP3s on Oculomucocutaneous syndrome

Videos on Oculomucocutaneous syndrome

Evidence Based Medicine

Cochrane Collaboration on Oculomucocutaneous syndrome

Bandolier on Oculomucocutaneous syndrome

TRIP on Oculomucocutaneous syndrome

Clinical Trials

Ongoing Trials on Oculomucocutaneous syndrome at Clinical Trials.gov

Trial results on Oculomucocutaneous syndrome

Clinical Trials on Oculomucocutaneous syndrome at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Oculomucocutaneous syndrome

NICE Guidance on Oculomucocutaneous syndrome

NHS PRODIGY Guidance

FDA on Oculomucocutaneous syndrome

CDC on Oculomucocutaneous syndrome

Books

Books on Oculomucocutaneous syndrome

News

Oculomucocutaneous syndrome in the news

Be alerted to news on Oculomucocutaneous syndrome

News trends on Oculomucocutaneous syndrome

Commentary

Blogs on Oculomucocutaneous syndrome

Definitions

Definitions of Oculomucocutaneous syndrome

Patient Resources / Community

Patient resources on Oculomucocutaneous syndrome

Discussion groups on Oculomucocutaneous syndrome

Patient Handouts on Oculomucocutaneous syndrome

Directions to Hospitals Treating Oculomucocutaneous syndrome

Risk calculators and risk factors for Oculomucocutaneous syndrome

Healthcare Provider Resources

Symptoms of Oculomucocutaneous syndrome

Causes & Risk Factors for Oculomucocutaneous syndrome

Diagnostic studies for Oculomucocutaneous syndrome

Treatment of Oculomucocutaneous syndrome

Continuing Medical Education (CME)

CME Programs on Oculomucocutaneous syndrome

International

Oculomucocutaneous syndrome en Espanol

Oculomucocutaneous syndrome en Francais

Business

Oculomucocutaneous syndrome in the Marketplace

Patents on Oculomucocutaneous syndrome

Experimental / Informatics

List of terms related to Oculomucocutaneous syndrome

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Oculomucocutaneous syndrome is characterized by keratoconjunctivitis sicca and by scarring, fibrosis, metaplasia, and shrinkage of the conjunctiva.[1] It is a drug side effect observed in practolol and eperisone. It is speculated that antibodies against drug metabolites cause the syndrome.[2]

References

  1. Wright, P (Mar 15, 1975). "Untoward effects associated with practolol administration: oculomucocutaneous syndrome". British Medical Journal. 1 (5958): 595–8. PMC 1672788. PMID 1125623.
  2. Amos, HE (Feb 18, 1978). "Possible role of antibody specific for a practolol metabolite in the pathogenesis of oculomucocutaneous syndrome". British Medical Journal. 1 (6110): 402–4. PMC 1602979. PMID 146533. Unknown parameter |coauthors= ignored (help)